Table 4.
Placebo (n = 6) |
CR (n = 7) |
||||
---|---|---|---|---|---|
Pre | Post | Pre | Post | p-value | |
Flanker Inhibitory Control and Attention (CS) | 8.3 ± 0.4 | 8.5 ± 0.5 | 8.9 ± 0.6 | 9.0 ± 0.7 | 0.720 |
List Sorting Working Memory (RS) | 18.5 ± 1.9 | 19.2 ± 1.0 | 20.4 ± 2.9 | 20.1 ± 2.0 | 0.467 |
Dimensional Change Card Sort (CS) | 8.5 ± 1.0 | 8.5 ± 0.8 | 8.6 ± 1.2 | 8.4 ± 2.0 | 0.585 |
Pattern Comparison Processing Speed (CS) | 71.8 ± 9.7 | 73.2 ± 13.3 | 69.6 ± 19.0 | 78.4 ± 14.7 | 0.175 |
Picture Sequence Memory (CS) | 613.6 ± 104.5 | 657.1 ± 71.3 | 630.2 ± 95.2 | 652.1 ± 71.5 | 0.527 |
Fluid Cognition Composite (ACS)* | 97.5 ± 14.3 | 102.7 ± 14.3 | 104.4 ± 24.2 | 110.6 ± 21.9 | 0.824 |
*Indicates a main effect of time regardless of treatment group (p ≤ 0.05) by paired t-tests.
CR; creatine monohydrate, CS = computed score, RS = raw score, ACS = age corrected standard score.